Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 86INDUSTRY 16NETWORK 5NIH 4OTHER_GOV 3UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Nasopharyngeal Neoplasms 1Locally Advanced Malignant Neoplasm 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cisplatin 2nedaplatin 1durvalumab 1camrelizumab 1apatinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Paclitaxel 1Irinotecan 1Drug Therapy 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Squamous Cell Carcinoma × Cisplatin × Clear all
NCT05522894 2022-08-31

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

ChineseAMS

Phase 2 Unknown
80 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04390958 2022-03-15

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase 2 Unknown
70 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡